1.
Arch Ital Urol Androl
; 68(1): 17-20, 1996 Feb.
Article
in Italian
| MEDLINE
| ID: mdl-8664914
ABSTRACT
Between 13.8% and 27% of all superficial bladder cancers are represented by pT1G3 neoplasm. In the Department of Urology of Policlinico S. Marco-Zingonia, between February 1988 and June 1994, we treated 22 patients suffering for pT1G3 bladder tumor. TUR-B has demonstrated to be a good approach for treatment of superficial bladder cancer, with low morbility; on the opposite side, we have to underline the high rate of recurrence and of progression of the urothelium disease. Now a day our best approach for the treatment of pT1G3 bladder tumor is represented by radical cystectomy supplied by chemotherapy.
Subject(s)
Carcinoma, Transitional Cell/therapy , Urinary Bladder Neoplasms/therapy , BCG Vaccine/administration & dosage , Carcinoma, Transitional Cell/pathology , Carcinoma, Transitional Cell/surgery , Chemotherapy, Adjuvant , Combined Modality Therapy , Cystectomy , Female , Follow-Up Studies , Humans , Lymph Node Excision , Male , Middle Aged , Neoplasm Recurrence, Local , Prognosis , Time Factors , Urinary Bladder/pathology , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/surgery
2.
Stomatol Mediterr
; 7(3): 377-84, 1987.
Article
in Italian
| MEDLINE
| ID: mdl-3508971